Vandana Menon

Summary

Publications

  1. pmc Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease
    Vandana Menon
    Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 6:7-13. 2011
  2. doi request reprint Serum bicarbonate and long-term outcomes in CKD
    Vandana Menon
    Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 56:907-14. 2010
  3. ncbi request reprint Relationship between homocysteine and mortality in chronic kidney disease
    Vandana Menon
    Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Boston, MA, USA
    Circulation 113:1572-7. 2006
  4. ncbi request reprint Relationship of phosphorus and calcium-phosphorus product with mortality in CKD
    Vandana Menon
    Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Boston, MA, USA
    Am J Kidney Dis 46:455-63. 2005
  5. doi request reprint Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA, USA
    Am J Kidney Dis 53:208-17. 2009
  6. ncbi request reprint Cystatin C as a risk factor for outcomes in chronic kidney disease
    Vandana Menon
    Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 147:19-27. 2007
  7. ncbi request reprint C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 68:766-72. 2005
  8. pmc Role of adipose tissue in determining muscle mass in patients with chronic kidney disease
    Carmen Castaneda-Sceppa
    Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA
    J Ren Nutr 17:314-22. 2007
  9. pmc Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease
    Jill Melendez Young
    Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 4:1115-20. 2009
  10. ncbi request reprint Body mass index and mortality in CKD
    Magdalena Madero
    Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 50:404-11. 2007

Detail Information

Publications22

  1. pmc Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease
    Vandana Menon
    Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 6:7-13. 2011
    ..Most deaths in autosomal dominant polycystic kidney disease (ADPKD) are attributable to cardiovascular disease (CVD). We examined novel CVD biomarkers in different stages of ADPKD...
  2. doi request reprint Serum bicarbonate and long-term outcomes in CKD
    Vandana Menon
    Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 56:907-14. 2010
    ..A low serum bicarbonate level is prevalent in chronic kidney disease (CKD); however, its relationship to long-term outcomes is unclear...
  3. ncbi request reprint Relationship between homocysteine and mortality in chronic kidney disease
    Vandana Menon
    Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Boston, MA, USA
    Circulation 113:1572-7. 2006
    ..The relationship between total homocysteine (tHcy) and outcomes has not been investigated in patients with chronic kidney disease stages 3 to 4...
  4. ncbi request reprint Relationship of phosphorus and calcium-phosphorus product with mortality in CKD
    Vandana Menon
    Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Boston, MA, USA
    Am J Kidney Dis 46:455-63. 2005
    ..There are limited data investigating relationships of phosphorus and calcium-phosphorus product with outcomes in patients with chronic kidney disease (CKD) stages 3 to 4...
  5. doi request reprint Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA, USA
    Am J Kidney Dis 53:208-17. 2009
    ..We examined the effect of a very low-protein diet on the development of kidney failure and death during long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study...
  6. ncbi request reprint Cystatin C as a risk factor for outcomes in chronic kidney disease
    Vandana Menon
    Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Ann Intern Med 147:19-27. 2007
    ....
  7. ncbi request reprint C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 68:766-72. 2005
    ..There are limited data evaluating the relationships between CRP, albumin, and outcomes in chronic kidney disease (CKD) stages 3 and 4...
  8. pmc Role of adipose tissue in determining muscle mass in patients with chronic kidney disease
    Carmen Castaneda-Sceppa
    Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA
    J Ren Nutr 17:314-22. 2007
    ..Arm muscle area was used as an indicator of muscle mass...
  9. pmc Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease
    Jill Melendez Young
    Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 4:1115-20. 2009
    ..This dimethylated amino acid accumulates in chronic kidney disease and may be involved in the pathophysiology of cardiovascular disease (CVD) in this population...
  10. ncbi request reprint Body mass index and mortality in CKD
    Magdalena Madero
    Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 50:404-11. 2007
    ..Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD)...
  11. ncbi request reprint Adiponectin and mortality in patients with chronic kidney disease
    Vandana Menon
    Tufts New England Medical Center, Division of Nephrology, 750 Washington Street, NEMC 391, Boston, MA 02111, USA
    J Am Soc Nephrol 17:2599-606. 2006
    ..Further studies are necessary to confirm this association and to elucidate the underlying mechanisms...
  12. ncbi request reprint Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts, USA
    J Am Soc Nephrol 16:3411-7. 2005
    ..43; P = 0.07). HbA(1c) is associated with increased mortality in nondiabetic kidney disease. Hyperglycemia may be a potential therapeutic target and HbA(1c) may be important as a risk stratification tool in this high-risk population...
  13. pmc Filtration markers may have prognostic value independent of glomerular filtration rate
    Navdeep Tangri
    Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
    J Am Soc Nephrol 23:351-9. 2012
    ..trace protein and cystatin C seem to provide more consistent prognostic information than creatinine...
  14. ncbi request reprint Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitamins
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 67:1539-46. 2005
    ..Data are limited on the determinants of homocysteine (tHcy) and its relationship with nutritional indices, and dietary protein intake, in the earlier stages of chronic kidney disease (CKD)...
  15. pmc Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
    Varun Chawla
    Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
    Clin J Am Soc Nephrol 5:1582-7. 2010
    ..Dyslipidemia confers a paradoxical survival advantage in patients with kidney failure. Data are limited in the earlier stages of chronic kidney disease (CKD)...
  16. pmc Homocysteine lowering and cardiovascular disease risk: lost in translation
    Jeremy Marcus
    Department of Medicine, Division of Nephrology, Tufts New England Medical Centre, Boston, Massachusetts 02111, USA
    Can J Cardiol 23:707-10. 2007
    ..Several more interventional trials are ongoing, but the available data thus far do not support screening for or treatment of hyperhomocysteinemia...
  17. ncbi request reprint Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease
    Vandana Menon
    Department of Medicine, Division of Clinical Care Research, Tufts New England Medical Center, Boston, MA, USA
    Am J Kidney Dis 42:44-52. 2003
    ..Data are limited regarding relationships between CRP levels and glomerular filtration rate (GFR), nutritional indices, and CVD in patients with earlier stages of kidney disease...
  18. pmc Alcohol consumption and kidney function decline in the elderly: alcohol and kidney disease
    Vandana Menon
    Division of Nephrology, Tufts Medical Center, Boston, MA, USA
    Nephrol Dial Transplant 25:3301-7. 2010
    ..Alcohol consumption appears to be protective for cardiovascular disease; however, its relationship with kidney disease is unclear...
  19. pmc Resistance training increases muscle mitochondrial biogenesis in patients with chronic kidney disease
    Vaidyanatha S Balakrishnan
    Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 5:996-1002. 2010
    ....
  20. ncbi request reprint The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combination
    Vandana Menon
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 45:223-32. 2005
  21. ncbi request reprint Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney disease
    Vandana Menon
    Department of Medicine, Division of Nephrology, Tufts University School of Medicine New England Medical Center, Boston, Massachusetts, USA
    Am J Cardiol 94:1290-3. 2004
    ....
  22. ncbi request reprint Cardiovascular risk factors in chronic kidney disease
    Vandana Menon
    Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    Kidney Int 68:1413-8. 2005